# Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke

Study · id `cardio:ct-nct03045055` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03045055](<https://clinicaltrials.gov/study/NCT03045055>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03045055

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT03045055. Randomized; quadruple masking; primary purpose treatment. Start 2020-08-01 (anticipated); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT03045055, source copy `cardio:ctgov-nct03045055-2020-07-27`, retrieved 2026-10-26)
- Planned start: 2020-08-01 (anticipated) (ClinicalTrials.gov record NCT03045055, source copy `cardio:ctgov-nct03045055-2020-07-27`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT03045055, source copy `cardio:ctgov-nct03045055-2020-07-27`, retrieved 2026-10-26)
- Completion: 2023-03-31 (anticipated) (ClinicalTrials.gov record NCT03045055, source copy `cardio:ctgov-nct03045055-2020-07-27`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03045055-2020-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke
- Acronym: REVISE-2
- Condition: Acute Stroke
- Intervention (Device): Remote ischemic conditioning.
- Intervention (Procedure): Endovascular treatment.
- Intervention (Device): Sham remote ischemic conditioning
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER
- Collaborator: Shengli Oilfield Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)
- Registry lists this organization as a collaborator: Shengli Oilfield Hospital (`cardio:org-shengli-oilfield-hospital`)

## Provenance

Content hash: d57b659139eea5d8410a00cd7d29f70ad0362b9fa2faec6f752875a39866d671
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
